Literature DB >> 412936

Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition.

R L Hintz, R Suskind, K Amatayakul, O Thanangkul, R Olson.   

Abstract

This study was undertaken to define the interrelationships of somatomedin, growth hormone, and an inhibitor of SM in protein-calorie malnutrition. Twenty-seven patients, eight to 60 months of age, were studied. Twenty-one well-nourished children acted as controls. SM was significantly depressed at Days 2 and 8 (p less than 0.01) but was not different from controls at Day 29 and 50. In ten out of 27 Day 2 samples and six out of 27 Day 8 samples an inhibitor was identified. When SM values were compared to simultaneous hGH levels, there was an inverse relationship. The low SM levels in the face of markedly elevated hGH levels suggests a functional block in the synthesis and/or release of SM.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 412936     DOI: 10.1016/s0022-3476(78)80099-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Infusion of zinc inhibits serum calcitonin levels in patients with various zinc status.

Authors:  S Nishiyama; T Nakamura; A Higashi; I Matsuda
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  Insulin-like growth factor I response during nutritional rehabilitation of persistent diarrhoea.

Authors:  Z A Bhutta; P Bang; E Karlsson; L Hagenäs; S Q Nizami; O Söder
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

3.  Somatomedin-C in zinc deficiency.

Authors:  Z T Cossack
Journal:  Experientia       Date:  1984-05-15

4.  Dietary components that regulate serum somatomedin-C concentrations in humans.

Authors:  W L Isley; L E Underwood; D R Clemmons
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

Review 5.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

6.  Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.

Authors:  A M Taylor; A Bush; A Thomson; P J Oades; J L Marchant; C Bruce-Morgan; J Holly; L Ahmed; D B Dunger
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 7.  Determinants of GH resistance in malnutrition.

Authors:  Pouneh K Fazeli; Anne Klibanski
Journal:  J Endocrinol       Date:  2014-01-27       Impact factor: 4.286

8.  Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children.

Authors:  R Rosskamp; M Becker; S Soetadji
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

9.  Decreased serum insulin-like growth factor-I associated with growth failure in newborn lambs with experimental cyanotic heart disease.

Authors:  D Bernstein; J R Jasper; R G Rosenfeld; R L Hintz
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 10.  Tamoxifen reduces serum insulin-like growth factor I (IGF-I).

Authors:  M N Pollak; H T Huynh; S P Lefebvre
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.